[1] 王佳伟, 代飞飞.单纯疱疹病毒性脑炎发展简史[J].中国现代神经疾病杂志, 2014, 14(8):660-663. [2] Desena A, Graves D, Warnack W, et al.Herpes simplex encephalitis as a potential cause of anti-N-methyl-D-aspartate receptor antibody encephalitis:report of 2 cases[J].J Neurol, 2014, 71(3):344-346. [3] Dalmau J, Tüzün E, Wu H Y, et al.Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma[J].Ann Neurol, 2007, 61(1):25-36. [4] Armangue T, Leypoldt F, Malaga I, et al.Herpes simplex virus encephalitis is a trigger of brain autoimmunity[J].Ann Neurol, 2014, 75(2):317-323. [5] De Tiège X, Rozenberg F, Des Portes V, et al.Herpes simplex encephalitis relapses in children:differentiation of two neurologic entities[J].Neurology, 2003, 61(2):241-243. [6] Pruss H, Finke C, Holtje M, et al.N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis[J].Ann Neurol, 2012, 72(6):902-911. [7] Armangue T, Titulaer M J, Málaga I, et al.Pediatric anti-N-methyl-D-aspartate receptor encephalitis—clinical analysis and novel findings in a series of 20 patients[J].J Pediatr, 2013, 162(4):850-856.e852. [8] Armangue T, Spatola M, Vlagea A, et al.Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis:a prospective observational study and retrospective analysis[J].Lancet Neurol, 2018, 17(9):760-772. [9] 付子垚, 任海涛, 薛岚平,等.成人病毒性脑炎后自身免疫性脑炎的临床特点[J].中华医学杂志, 2020, 100(25):1933-1936. [10] Gelfand J M.Autoimmune encephalitis after herpes simplex encephalitis:insights into pathogenesis[J].Lancet Neurol, 2018, 17(9):733-735. [11] 赵宛玉, 杜敢琴, 张在行.单纯疱疹病毒性脑炎继发抗NMDAR脑炎1例报道并文献复习[J].卒中与神经疾病, 2019, 26(1):118-119. [12] 刘磊,宋兆慧,郭晶,等.国人45例抗N-甲基-D-天冬氨酸受体脑炎病例分析[J].中华神经科杂志, 2014, 47(7):474-480. [13] Alexopoulos H, Akrivou S, Mastroyanni S, et al.Postherpes simplex encephalitis:a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy[J].Ther Adv Neurol Disord, 2018, 11:175628 6418768778. [14] Michael J B, Siddharama P, Vanda A L, et al.Herpes simplex virus 1 encephalitis associated with voltage-gated calcium channel autoimmunity[J].Neurology,2015, 85(24):2176-2177. [15] Linnoila J, Binnicker M, Majed M, et al.CSF herpes virus and autoantibody profiles in the evaluation of encephalitis[J].Neurol Neuroimmunol, 2016, 3(4):e245. [16] Tian M, Li J, Lei W, et al.Japanese encephalitis virus-induced anti-N-methyl-D-aspartate receptor encephalitis:a case report and review of literature[J].Neuropediatrics, 2019, 50(2):111-115. [17] Panariello A, Bassetti R, Radice A, et al.Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient:A case report[J].Brain Behav Immun, 2020, 87:179-181. [18] Liu J, Liu L, Kang W, et al.Cytokines/chemokines:potential biomarkers for non-paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis[J].Front Neurol, 2020, 11:582296. [19] Zimmermann J, Hafezi W, Dockhorn A, et al.Enhanced viral clearance and reduced leukocyte infiltration in experimental herpes encephalitis after intranasal infection of CXCR3-deficient mice[J].J Neurovirol, 2017, 23(3):394-403. [20] Gnann J W, Whitley R J.Herpes simplex encephalitis:an update[J].Curr Infect Dis Rep, 2017, 19(3):13. [21] Mielcarska M, Bossowska-Nowicka M, Toka F.Functional failure of TLR3 and its signaling components contribute to herpes simplex encephalitis[J].J Neuroimmunol, 2018, 316:65-73. [22] Sironi M, Peri A, Cagliani R, et al.TLR3 mutations in adult patients with herpes simplex virus and varicella-zoster virus encephalitis[J].J Infect Dis, 2017, 215(9):1430-1434. [23] Lim H, Seppä nen M, Hautala T, et al.TLR3 deficiency in herpes simplex encephalitis:high allelic heterogeneity and recurrence risk[J].Neurology, 2014, 83(21):1888-1897. [24] Vogrig A, Muñiz-Castrillo S, Desestret V, et al.Pathophysiology of paraneoplastic and autoimmune encephalitis:genes, infections, and checkpoint inhibitors[J].Therapeu Adv Neurol Disord, 2020, 13:1756286420932797. [25] Linnoila J, Pulli B, Armangué T, et al.Mouse model of anti-NMDA receptor post-herpes simplex encephalitis[J].Neurol Neuroimmunol, 2019, 6(2):e529. [26] Moloney P B, Hutchinson S, Heskin J, et al.Possible N-methyl-D-aspartate receptor antibody-mediated encephalitis in the setting of HIV cerebrospinal fluid escape[J].J Neurol, 2020, 267(5):1348-1352. [27] Zandman-Goddard G, Shoenfeld Y.HIV and autoimmunity[J].Autoimmun Rev, 2002, 1(6):329-337. [28] Massabki P, Accetturi C, Nishie I, et al.Clinical implications of autoantibodies in HIV infection[J].AIDS (London, England), 1997, 11(15):1845-1850. [29] Cunill V, Arboleya S, Jiménez M, et al.Neuronal surface antibodies in HIV-infected patients with isolated psychosis[J].J Neuroimmunol, 2016, 301:49-52. [30] Gilbert G.Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis:case report[J].Neurology, 2014, 82(22):2041. [31] Schein F, Gagneux-Brunon A, Antoine J C, et al.Anti-N-methyl-D-aspartate receptor encephalitis after Herpes simplex virus-associated encephalitis:an emerging disease with diagnosis and therapeutic challenges[J].Infection, 2017, 45(4):545-549. [32] Mohammad S S, Sinclair K, Pillai S, et al.Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor[J].Mov Disord, 2014, 29(1):117-122. [33] Dale R, Merheb V, Pillai S, et al.Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders[J].Brain, 2012, 135:3453-3468. [34] 中华神经病学分会.中国自身免疫性脑炎诊治专家共识[J].中华神经科杂志, 2017,50(2):91-98. [35] Titulaer M J, McCracken L, Gabilondo I, et al.Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis:an observational cohort study[J].Lancet Neurol, 2013, 12(2):157-165. [36] Armangue T, Leypoldt F, Dalmau J.Autoimmune encephalitis as differential diagnosis of infectious encephalitis[J].Curr Opin Neurol, 2014, 27(3):361-368. [37] Armangue T, Moris G, Cantarín-Extremera V, et al.Autoimmune post-herpes simplex encephalitis of adults and teenagers[J].Neurology, 2015, 85(20):1736-1743. |